These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 11197334)

  • 1. Synthesis of tetrasubstituted pyrazoles containing pyridinyl substituents.
    Jansa J; Schmidt R; Mamuye AD; Castoldi L; Roller A; Pace V; Holzer W
    Beilstein J Org Chem; 2017; 13():895-902. PubMed ID: 28546847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expedited Route to Fully Substituted Amino-Pyrazole Building Blocks and Their Further Transformations.
    Kuleshova O; Khilya O; Volovenko Y; Mallet-Ladeira S; Dyakonenko V; Gras E
    ACS Omega; 2017 Dec; 2(12):8911-8927. PubMed ID: 31457419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrooxidation Is a Promising Approach to Functionalization of Pyrazole-Type Compounds.
    Lyalin BV; Sigacheva VL; Kudinova AS; Neverov SV; Kokorekin VA; Petrosyan VA
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regioselective Synthesis, Structural Characterization, and Antiproliferative Activity of Novel Tetra-Substituted Phenylaminopyrazole Derivatives.
    Lusardi M; Profumo A; Rotolo C; Iervasi E; Rosano C; Spallarossa A; Ponassi M
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design and optimization of selenophenes with basic side chains as novel potent selective estrogen receptor modulators (SERMs) for breast cancer therapy.
    Luo J; Hu Z; Xiao Y; Yang T; Dong C; Huang J; Zhou HB
    Medchemcomm; 2017 Jul; 8(7):1485-1497. PubMed ID: 30108860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins.
    Ippagunta SK; Pollock JA; Sharma N; Lin W; Chen T; Tawaratsumida K; High AA; Min J; Chen Y; Guy RK; Redecke V; Katzenellenbogen JA; Häcker H
    Sci Signal; 2018 Aug; 11(543):. PubMed ID: 30108181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 4-(substituted styryl/alkenyl)-3,5-bis(4-hydroxyphenyl)-isoxazoles as ligands for the estrogen receptor.
    Haddad T; Gershman R; Dilis R; Labaree D; Hochberg RB; Hanson RN
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5999-6003. PubMed ID: 22906893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human estrogen receptor (ER)alpha mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action.
    Paulmurugan R; Tamrazi A; Katzenellenbogen JA; Katzenellenbogen BS; Gambhir SS
    Mol Endocrinol; 2008 Jul; 22(7):1552-64. PubMed ID: 18451095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site.
    Anstead GM; Carlson KE; Katzenellenbogen JA
    Steroids; 1997 Mar; 62(3):268-303. PubMed ID: 9071738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CoMSIA and docking study of rhenium based estrogen receptor ligand analogs.
    Wolohan P; Reichert DE
    Steroids; 2007 Mar; 72(3):247-60. PubMed ID: 17280694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor.
    Stauffer SR; Huang Y; Coletta CJ; Tedesco R; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):141-50. PubMed ID: 11197334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
    Stauffer SR; Huang YR; Aron ZD; Coletta CJ; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):151-61. PubMed ID: 11197335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
    Stauffer SR; Coletta CJ; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2000 Dec; 43(26):4934-47. PubMed ID: 11150164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens.
    Fink BE; Mortensen DS; Stauffer SR; Aron ZD; Katzenellenbogen JA
    Chem Biol; 1999 Apr; 6(4):205-19. PubMed ID: 10099132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.